|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street SW |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lucia DiVenere |
Date | 1/20/2015 2:11:15 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC).
Comprehensive Sexuality Education funding (general); International family planning; Violence Against Women Programs; Indian Health Service.
Budget Control Act; Maternal Mortality Reviews; National Fetal Infant Mortality Review (HRSA); Obesity Research, Treatment and Prevention (HHS); Department of Defense (DOD); Ovarian Cancer Research Program; Health Disparities (HHS); Safe Motherhood (CDC); Preterm Birth Research (NIH); Title V Block Grant (HRSA); Title X, Family Planning; Reproductive Health; Birth Defects; Medicaid and Medicare funding; Department of Agriculture (USDA), Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), Drug Dependence Research (NIH; FY15 Appropriations, Labor-HHS and Department of Defense; FY15 Budget House, Senate and Presidential. FY16 Presidential
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Defense - Dept of (DOD), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), U.S. SENATE, Health & Human Services - Dept of (HHS), Agency for Health Care Policy & Research, Agriculture - Dept of (USDA), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Emergency Contraception (general; Health Care Reform Implementation. Drug Dependence (general); HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general)Obesity (general); Disparities (general); Prevention and Public Health Trust Fund (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); CMS Provider Penalties (general)Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); CMS Health IT incentive program, meaningful use State 3; Immigrant Health Care Access; S. 237, Advancing FASD Research, Prevention and Services Act; S. 333/H.R. 728, Access to Birth Control Act; H.R. 1331, Electronic Health Records Improvements Act; H.R. 1201, Training Tomorrows Doctors Today Act; H.R. 896/X. 425, Quality Care for Moms and Babies Act; H.R. 1281/S. 1417, Newborn Screening Saves Lives Reauthorization Act; H.R. 36/S. 961, Health Care Safety Net Enhancement Act; H.R. 1975/S. 942 Pregnant Workers Fairness Act; Implementation of H.R. 3204, the Drug Quality and Security Act; H.R. 1915/S. 907 GEDI Act; H.R. 5364 CHIP Extension and Improvement ACT; S. 1009, Chemical Safety Improvement Act; H.R. 2286, Maximizing Optimal Maternity Services for the 21st Century Act; H.R. 4106, Saving Lives, Saving Costs Act; Pregnancy Discrimination (general); S. 1124, BPA in Food Packaging Right to Know Act; H.R. 4240, HEAL Immigrant Women and Families Act; H.R. 4216, Maternal Health Accountability Act; S. 1978, Increasing Primary Care Access Act; H.R. 4435/S. 2410 Carl Levin National Defense Authorization Act for Fiscal Year 2015; H.R. 4385, To Amend the Public Health Service Act to provide for the Designation of maternity care health professional shortage areas; H.R. 4492/S. 1994 TRICARE Moms Improvement Act of 2014; H.R. 4750/S. 1769, Standard of Care Protection Act of 2014; S. 2461, CHIP Extension Act of 2014; H.R. 4888 CRIB Act; S. 2722 Protecting our Infants Act; H.R. 5524/S. 2687 Access to contraception for Women Service Members and Dependents Act; 21st Century Cures; H.R> 5294 Health Equity and Accountability Act; H.R. 5539 Except certain transfers of value from reporting requirements under Sunshine Act; H.R. 5486 Child Nicotine Poisoning Prevention Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Defense - Dept of (DOD), Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Agency for Health Care Policy & Research, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS), White House Office, Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 2000/H.R. 4015, Sustainable Growth Rate Formula Reform; Medicaid (general); S. 2694/H.R. 5723 Ensuring Access to Primary Care for Women and Children Act; S. 3007 Ensuring Enhanced Access to Primary Care Act; 2015 Physician Fee Schedule.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |